The Prolonged Half-Life of the p53 Missense Variant R248Q Promotes Accumulation and Heterotetramer Formation with Wild-Type p53 to Exert the Dominant-Negative Effect

Journal:

Cancer Research

Published:

2025-06-01

DOI:

10.1158/0008-5472.can-24-1136

Affiliations:

11

Authors:

22

Go to article

Institutions	Authors	Share
University Hospital Zurich (UHZ), Switzerland	15.000000 15.000000	0.68
Dana-Farber Cancer Institute (DFCI), United States of America (USA)	2.000000	0.09
Broad Institute of MIT and Harvard, United States of America (USA)	1.000000	0.05
University of Turku (UTU), Finland	1.000000	0.05
Boston Children's Hospital (BCH), United States of America (USA)	1.000000	0.05
Massachusetts General Hospital Cancer Center, United States of America (USA)	1.000000	0.05
University of Zurich (UZH), Switzerland	0.500000	0.02
Utrecht University (UU), Netherlands	0.500000	0.02

Interested in Oncology and Carcinogenesis?